176 related articles for article (PubMed ID: 25481051)
1. Biological functions of hyaluronan and cytokine-inducible deubiquitinating enzymes.
Ramakrishna S; Suresh B; Baek KH
Biochim Biophys Acta; 2015 Jan; 1855(1):83-91. PubMed ID: 25481051
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms and functions of cytokine-inducible deubiquitinating enzymes.
Lim KH; Ramakrishna S; Baek KH
Cytokine Growth Factor Rev; 2013 Oct; 24(5):427-31. PubMed ID: 23773437
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.
Shin JM; Yoo KJ; Kim MS; Kim D; Baek KH
BMC Genomics; 2006 Nov; 7():292. PubMed ID: 17109758
[TBL] [Abstract][Full Text] [Related]
4. Deubiquitinases (DUBs) and DUB inhibitors: a patent review.
Farshi P; Deshmukh RR; Nwankwo JO; Arkwright RT; Cvek B; Liu J; Dou QP
Expert Opin Ther Pat; 2015; 25(10):1191-1208. PubMed ID: 26077642
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronan binding motifs of USP17 and SDS3 exhibit anti-tumor activity.
Ramakrishna S; Suresh B; Bae SM; Ahn WS; Lim KH; Baek KH
PLoS One; 2012; 7(5):e37772. PubMed ID: 22662218
[TBL] [Abstract][Full Text] [Related]
6. Cytokine-regulated protein degradation by the ubiquitination system.
Baek KH
Curr Protein Pept Sci; 2006 Apr; 7(2):171-7. PubMed ID: 16611142
[TBL] [Abstract][Full Text] [Related]
7. Deubiquitinase inhibition as a cancer therapeutic strategy.
D'Arcy P; Wang X; Linder S
Pharmacol Ther; 2015 Mar; 147():32-54. PubMed ID: 25444757
[TBL] [Abstract][Full Text] [Related]
8. Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.
Ramakrishna S; Suresh B; Kang IC; Baek KH
Hybridoma (Larchmt); 2010 Aug; 29(4):311-9. PubMed ID: 20715989
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer.
Wang SJ; Bourguignon LY
Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):771-8. PubMed ID: 16847188
[TBL] [Abstract][Full Text] [Related]
10. Targeting Deubiquitinating Enzymes in Glioblastoma Multiforme: Expectations and Challenges.
Jin WL; Mao XY; Qiu GZ
Med Res Rev; 2017 May; 37(3):627-661. PubMed ID: 27775833
[TBL] [Abstract][Full Text] [Related]
11. Role of hyaluronan and CD44 in in vitro branching morphogenesis of ureteric bud cells.
Pohl M; Sakurai H; Stuart RO; Nigam SK
Dev Biol; 2000 Aug; 224(2):312-25. PubMed ID: 10926769
[TBL] [Abstract][Full Text] [Related]
12. Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion.
Mohamadzadeh M; DeGrendele H; Arizpe H; Estess P; Siegelman M
J Clin Invest; 1998 Jan; 101(1):97-108. PubMed ID: 9421471
[TBL] [Abstract][Full Text] [Related]
13. DUBs, the regulation of cell identity and disease.
Heideker J; Wertz IE
Biochem J; 2015 Jan; 465(1):1-26. PubMed ID: 25631680
[TBL] [Abstract][Full Text] [Related]
14. Deubiquitinases in cancer.
Wei R; Liu X; Yu W; Yang T; Cai W; Liu J; Huang X; Xu GT; Zhao S; Yang J; Liu S
Oncotarget; 2015 May; 6(15):12872-89. PubMed ID: 25972356
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronan-CD44 promotes phospholipase C-mediated Ca2+ signaling and cisplatin resistance in head and neck cancer.
Wang SJ; Bourguignon LY
Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):19-24. PubMed ID: 16415424
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44.
Kim HR; Wheeler MA; Wilson CM; Iida J; Eng D; Simpson MA; McCarthy JB; Bullard KM
Cancer Res; 2004 Jul; 64(13):4569-76. PubMed ID: 15231668
[TBL] [Abstract][Full Text] [Related]
17. Advances and advantages of nanomedicine in the pharmacological targeting of hyaluronan-CD44 interactions and signaling in cancer.
Skandalis SS; Gialeli C; Theocharis AD; Karamanos NK
Adv Cancer Res; 2014; 123():277-317. PubMed ID: 25081534
[TBL] [Abstract][Full Text] [Related]
18. The role of the deubiquitinating enzyme DUB3/USP17 in cancer: a narrative review.
Yang GF; Zhang X; Su YG; Zhao R; Wang YY
Cancer Cell Int; 2021 Aug; 21(1):455. PubMed ID: 34454495
[TBL] [Abstract][Full Text] [Related]
19. Balancing act: deubiquitinating enzymes in the nervous system.
Todi SV; Paulson HL
Trends Neurosci; 2011 Jul; 34(7):370-82. PubMed ID: 21704388
[TBL] [Abstract][Full Text] [Related]
20. The role of deubiquitinating enzymes in cancer drug resistance.
Tanguturi P; Kim KS; Ramakrishna S
Cancer Chemother Pharmacol; 2020 Apr; 85(4):627-639. PubMed ID: 32146496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
